Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure

Sherin I Hashem1, Cynthia N Perry1, Matthieu Bauer1

  • 1Division of Cardiology, Department of Medicine.

Insights

Danon disease, caused by LAMP-2 mutations, impairs cardiomyocyte autophagy leading to heart failure. Antioxidant treatment reduced cell death, suggesting a potential therapy for this genetic cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Cell Biology

Background:

  • Danon disease is a genetic cardiomyopathy linked to impaired autophagy from mutations in lysosomal-associated membrane protein 2 (LAMP-2).
  • Autophagy is crucial for cardiomyocyte health, but its role in Danon disease pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cellular dysfunction and death in Danon disease cardiomyocytes.
  • To model Danon disease using patient-derived induced pluripotent stem cells (iPSCs).

Main Methods:

  • Generated iPSC-derived cardiomyocytes (iPSC-CMs) from two Danon disease patients with distinct LAMP-2 mutations.
  • Assessed autophagic flux, cardiomyocyte structure, calcium handling, oxidative stress, and apoptosis in Danon iPSC-CMs.
  • Evaluated the therapeutic potential of the antioxidant N-acetylcysteine.

Main Results:

  • Danon iPSC-CMs displayed impaired autophagic flux, hypertrophy, abnormal calcium handling, and increased apoptosis.
  • Mitochondrial oxidative stress was significantly elevated in Danon iPSC-CMs.
  • N-acetylcysteine treatment reduced apoptosis in Danon iPSC-CMs, indicating a role for free radical scavenging.

Conclusions:

  • LAMP-2 deficiency impairs autophagic flux, leading to oxidative stress and cardiomyocyte apoptosis in Danon disease.
  • Human iPSC-CMs provide a valuable model for studying Danon disease mechanisms.
  • Antioxidant therapy targeting free radicals shows promise for treating Danon disease, warranting further in vivo investigation.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K